Mumbai: Private equity firm Carlyle Group-backed Indegene has filed draft papers with the Securities and Exchange Board of India (Sebi) for an initial public offer, consisting of fresh issue of shares and an offer for sale by existing shareholders. Through the fresh issue of shares, the Bengaluru-based life science technology company plans to raise Rs 950 crore…
Read More
About The Author
